US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

39.04

-0.1550-0.40%

Volume:107.71K

Turnover:4.21M

Market Cap:2.77B

PE:-14.79

High:39.50

Open:39.19

Low:38.05

Close:39.19

52wk High:94.90

52wk Low:15.80

Shares:70.84M

Float Shares:51.39M

Volume Ratio:0.25

T/O Rate:0.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.6400

EPS(LYR):-2.3852

ROE:-15.00%

ROA:-11.57%

PB:1.91

PE(LYR):-16.37

Loading ...

Overview Company News Filings

Structure Therapeutics CEO Says Strategic Partner for Commercialization of Its Medicine Needs to Have Strong Relationships With Primary Care Doctors

THOMSON REUTERS

What to Watch in the Day Ahead - Wednesday, January 14

Structure Therapeutics rises 14.1%

What to Watch in the Day Ahead - Tuesday, January 13

Funding for Risky Biotechs Is Returning -- WSJ

Structure Therapeutics Inc. unveils oral obesity treatment pipeline in new corporate presentation

Septerna to Present GPCR Pipeline Updates at JPM Conference

Press Release: Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer

Weight-Loss Drugmakers' Stocks Jump. Structure Therapeutics up 5%; Eli Lilly Rises 4% to Record High; Amgen up 3%; Roche, Novo up Around 2%

Tiger Newspress

Weight-Loss Drugmakers' Stocks Jump. Arrowhead up over 17%; Structure Therapeutics up over 6%; Novo Nordisk up 5%; Viking, Pfizer, Eli Lilly up Around 2%

Tiger Newspress

BRIEF-Structure Therapeutics Inc - Gasherbrum Entered Agreement With Genentech And Roche - SEC Filing

Structure Therapeutics Inc - Genentech to Pay Gasherbrum $100 Mln - SEC Filing

THOMSON REUTERS

Structure Therapeutics Subsidiary Grants Genentech $100 Million License for GLP-1 Patents

The Year-End 2025 Biotech Rally And What It Means For 2026

Benzinga_recent_news

BUZZ-Structure Therapeutics doubles while other obesity drug developers decline

Structure Therapeutics Inc. : H.c. Wainwright Raises Target Price to $90 From $60

THOMSON REUTERS

BUZZ-Obesity pill maker Structure gains after Lilly's pill shows promising trial data

BRIEF-Structure Therapeutics Starts Phase 1 Study Of Oral Amylin Agonist ACCG‑2671

Structure Therapeutics Launches Phase 1 Trial of Oral Amylin Agonist ACCG-2671 for Obesity

Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist Accg-2671 for the Treatment of Obesity

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GPCR/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"GPCR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GPCR\",,,,,undefined,":{"symbol":"GPCR","market":"US","secType":"STK","nameCN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","latestPrice":39.035,"timestamp":1779814845658,"preClose":39.19,"halted":0,"volume":107705,"delay":0,"changeRate":-0.003955090584332768,"floatShares":51394700,"shares":70841812,"eps":-2.64,"marketStatus":"Trading","change":-0.155,"latestTime":"05-26 13:00:50 EDT","open":39.19,"high":39.5,"low":38.05,"amount":4208508.251999999,"amplitude":0.036999,"askPrice":39.15,"askSize":100,"bidPrice":38.96,"bidSize":70,"shortable":3,"etf":0,"ttmEps":-2.64,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1779825600000},"marketStatusCode":2,"adr":0,"adrRate":3,"listingDate":1675400400000,"exchange":"NASDAQ","adjPreClose":39.19,"preHourTrading":{"tag":"盘前","latestPrice":39,"preClose":39.19,"latestTime":"09:15 EDT","volume":130,"amount":5120.19456,"timestamp":1779801313889,"change":-0.19,"changeRate":-0.004848,"amplitude":0.040214},"postHourTrading":{"tag":"盘后","latestPrice":39,"preClose":39.19,"latestTime":"19:59 EDT","volume":11454,"amount":448759.734,"timestamp":1779494379920,"change":-0.19,"changeRate":-0.004848,"amplitude":0.004848},"volumeRatio":0.253534,"impliedVol":0.5943,"impliedVolPercentile":0.0956},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GPCR\",,,,,undefined,":{"symbol":"GPCR","floatShares":51394700,"roa":"-11.57%","roe":"-15.00%","lyrEps":-2.385222,"volumeRatio":0.253534,"shares":70841812,"dividePrice":0,"high":39.5,"amplitude":0.036999,"preClose":39.19,"low":38.05,"week52Low":15.8,"pbRate":"1.91","week52High":94.9,"institutionHeld":0,"latestPrice":39.035,"committee":-0.176471,"eps":-2.64,"divideRate":0,"volume":107705,"delay":0,"ttmEps":-2.64,"open":39.19,"prevYearClose":69.55,"prevWeekClose":39.19,"prevMonthClose":41.45,"prevQuarterClose":48.2,"fiveDayClose":36.11,"twentyDayClose":45.33,"sixtyDayClose":62.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GPCR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-07","symbol":"GPCR","fiscalQuarterEnding":"2026/03","expectedEps":-0.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.35},{"market":"US","date":"2026-02-26","symbol":"GPCR","fiscalQuarterEnding":"2025/12","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-11-06","symbol":"GPCR","fiscalQuarterEnding":"2025/09","expectedEps":-0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.37},{"market":"US","date":"2025-08-06","symbol":"GPCR","fiscalQuarterEnding":"2025/06","expectedEps":-0.28,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.36},{"market":"US","date":"2025-05-08","symbol":"GPCR","fiscalQuarterEnding":"2025/03","expectedEps":-0.24,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.27}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GPCR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GPCR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6111,"hold":0.0556,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6111,"analysts":18,"updateTime":1777521600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GPCR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GPCR","date":"2026-05-22","current":-14.785985,"percent":0.673292,"low":-50.180001,"twenty":-24.924896,"median":-19.829477,"eighty":-10.235281,"high":-5.211405,"avg":-19.400947,"sd":8.538397,"marketCap":2756851382},"quantilePoints":[{"date":"2023-02-03","current":-25.001825,"twenty":-43.272389,"median":-43.272389,"eighty":-32.310051,"marketCap":951294422},{"date":"2023-02-10","current":-22.116999,"twenty":-35.964163,"median":-23.496907,"eighty":-22.21316,"marketCap":841529681},{"date":"2023-02-17","current":-21.285207,"twenty":-24.521021,"median":-22.645883,"eighty":-21.915061,"marketCap":809880847},{"date":"2023-02-24","current":-23.36709,"twenty":-23.715192,"median":-22.645883,"eighty":-21.847749,"marketCap":889094402},{"date":"2023-03-03","current":-25.530709,"twenty":-24.422936,"median":-22.718004,"eighty":-21.972757,"marketCap":971417957},{"date":"2023-03-10","current":-22.636267,"twenty":-24.85566,"median":-22.790125,"eighty":-22.063149,"marketCap":861287334},{"date":"2023-03-17","current":-22.232392,"twenty":-24.422936,"median":-22.70358,"eighty":-22.09392,"marketCap":845920270},{"date":"2023-03-24","current":-21.876596,"twenty":-23.762311,"median":-22.568955,"eighty":-21.891982,"marketCap":832382619},{"date":"2023-03-31","current":-16.960589,"twenty":-23.565181,"median":-22.314128,"eighty":-21.634271,"marketCap":870434396},{"date":"2023-04-06","current":-17.823234,"twenty":-23.376706,"median":-22.232392,"eighty":-21.285207,"marketCap":914706175},{"date":"2023-04-14","current":-17.473898,"twenty":-23.36709,"median":-22.116999,"eighty":-18.643102,"marketCap":896777933},{"date":"2023-04-21","current":-17.210114,"twenty":-23.194,"median":-22.059302,"eighty":-17.623613,"marketCap":883240282},{"date":"2023-04-28","current":-17.815518,"twenty":-23.078607,"median":-21.876596,"eighty":-17.586227,"marketCap":914310203},{"date":"2023-05-05","current":-17.709107,"twenty":-22.982446,"median":-21.689083,"eighty":-17.623613,"marketCap":908849077},{"date":"2023-05-12","current":-17.00755,"twenty":-22.790125,"median":-21.491953,"eighty":-17.586227,"marketCap":956079400},{"date":"2023-05-19","current":-15.32957,"twenty":-22.780509,"median":-20.818827,"eighty":-17.473898,"marketCap":861751761},{"date":"2023-05-26","current":-19.808636,"twenty":-22.761276,"median":-19.808636,"eighty":-17.466769,"marketCap":1113542462},{"date":"2023-06-02","current":-21.830342,"twenty":-22.668962,"median":-20.674586,"eighty":-17.472472,"marketCap":1227192672},{"date":"2023-06-09","current":-23.110075,"twenty":-22.668962,"median":-21.38858,"eighty":-17.563702,"marketCap":1299132872},{"date":"2023-06-16","current":-21.061141,"twenty":-22.668962,"median":-21.491953,"eighty":-17.586212,"marketCap":1183952020},{"date":"2023-06-23","current":-21.782692,"twenty":-22.640113,"median":-21.568882,"eighty":-17.608538,"marketCap":1224514048},{"date":"2023-06-30","current":-27.561913,"twenty":-22.772816,"median":-21.571672,"eighty":-17.623492,"marketCap":1549392931},{"date":"2023-07-07","current":-24.451072,"twenty":-23.059375,"median":-21.612515,"eighty":-17.625039,"marketCap":1374517018},{"date":"2023-07-14","current":-21.428724,"twenty":-23.103781,"median":-21.707815,"eighty":-17.644282,"marketCap":1204615694},{"date":"2023-07-21","current":-23.069233,"twenty":-23.103781,"median":-21.780436,"eighty":-17.700571,"marketCap":1296836908},{"date":"2023-07-28","current":-23.552536,"twenty":-23.333385,"median":-21.782692,"eighty":-17.727736,"marketCap":1324005814},{"date":"2023-08-04","current":-21.592094,"twenty":-23.51737,"median":-21.782692,"eighty":-17.804907,"marketCap":1213799550},{"date":"2023-08-11","current":-19.978813,"twenty":-23.374783,"median":-21.781564,"eighty":-17.817061,"marketCap":1123108978},{"date":"2023-08-18","current":-16.072919,"twenty":-23.333385,"median":-21.735043,"eighty":-17.644282,"marketCap":1053531639},{"date":"2023-08-25","current":-16.66259,"twenty":-23.197654,"median":-21.646551,"eighty":-17.586168,"marketCap":1092182818},{"date":"2023-09-01","current":-16.458249,"twenty":-23.185384,"median":-21.592094,"eighty":-17.468195,"marketCap":1078788845},{"date":"2023-09-08","current":-16.680105,"twenty":-23.150918,"median":-21.568882,"eighty":-17.319402,"marketCap":1093330873},{"date":"2023-09-15","current":-18.326514,"twenty":-23.110075,"median":-21.460338,"eighty":-17.211393,"marketCap":1201248026},{"date":"2023-09-22","current":-19.937893,"twenty":-23.078607,"median":-21.067948,"eighty":-17.309925,"marketCap":1306869070},{"date":"2023-09-29","current":-21.876218,"twenty":-23.069233,"median":-21.012104,"eighty":-17.319402,"marketCap":1433920470},{"date":"2023-10-06","current":-37.165618,"twenty":-23.194,"median":-21.285207,"eighty":-17.395476,"marketCap":2436094784},{"date":"2023-10-13","current":-44.162453,"twenty":-23.552536,"median":-21.525005,"eighty":-17.459473,"marketCap":2894716299},{"date":"2023-10-20","current":-45.222784,"twenty":-23.852048,"median":-21.571672,"eighty":-17.466769,"marketCap":2964217822},{"date":"2023-10-27","current":-47.275909,"twenty":-23.892891,"median":-21.592094,"eighty":-17.469621,"marketCap":3098794020},{"date":"2023-11-03","current":-48.538851,"twenty":-24.328544,"median":-21.646551,"eighty":-17.490333,"marketCap":3181576088},{"date":"2023-11-10","current":-38.273225,"twenty":-24.864943,"median":-21.735043,"eighty":-17.514986,"marketCap":2508695101},{"date":"2023-11-17","current":-27.570058,"twenty":-25.04304,"median":-21.781564,"eighty":-17.543453,"marketCap":2122673903},{"date":"2023-11-24","current":-32.691508,"twenty":-27.365869,"median":-21.782692,"eighty":-17.586168,"marketCap":2516984612},{"date":"2023-12-01","current":-35.337541,"twenty":-28.3175,"median":-21.830342,"eighty":-17.593664,"marketCap":2720707940},{"date":"2023-12-08","current":-37.983573,"twenty":-33.138225,"median":-21.904522,"eighty":-17.623452,"marketCap":2924431267},{"date":"2023-12-15","current":-37.177707,"twenty":-34.105722,"median":-22.049686,"eighty":-17.625039,"marketCap":2862386033},{"date":"2023-12-22","current":-20.939825,"twenty":-34.105722,"median":-22.001606,"eighty":-17.644282,"marketCap":1612198995},{"date":"2023-12-29","current":-23.446258,"twenty":-34.065552,"median":-22.068918,"eighty":-17.684898,"marketCap":1805174329},{"date":"2024-01-05","current":-26.187472,"twenty":-34.000259,"median":-22.102574,"eighty":-17.702705,"marketCap":2016225834},{"date":"2024-01-12","current":-28.789086,"twenty":-33.67371,"median":-22.232392,"eighty":-17.746366,"marketCap":2216529345},{"date":"2024-01-19","current":-27.710368,"twenty":-33.290514,"median":-22.259189,"eighty":-17.804907,"marketCap":2133476670},{"date":"2024-01-26","current":-26.745867,"twenty":-33.138225,"median":-22.283013,"eighty":-17.817061,"marketCap":2059217807},{"date":"2024-02-02","current":-28.598724,"twenty":-32.691508,"median":-22.44298,"eighty":-17.823234,"marketCap":2201872991},{"date":"2024-02-09","current":-29.823387,"twenty":-32.667396,"median":-22.576119,"eighty":-17.835432,"marketCap":2296162205},{"date":"2024-02-16","current":-28.427399,"twenty":-32.293017,"median":-22.636267,"eighty":-17.890184,"marketCap":2188682272},{"date":"2024-02-23","current":-26.035182,"twenty":-31.181303,"median":-22.647193,"eighty":-17.91403,"marketCap":2004500750},{"date":"2024-03-01","current":-25.743294,"twenty":-31.092467,"median":-22.775115,"eighty":-17.959972,"marketCap":1982027673},{"date":"2024-03-08","current":-22.849791,"twenty":-30.933832,"median":-22.849791,"eighty":-18.031985,"marketCap":1759251085},{"date":"2024-03-15","current":-18.291889,"twenty":-29.823387,"median":-22.775115,"eighty":-18.031985,"marketCap":1639319082},{"date":"2024-03-22","current":-22.815466,"twenty":-29.601298,"median":-22.761276,"eighty":-18.070517,"marketCap":2044722039},{"date":"2024-03-28","current":-22.311113,"twenty":-29.398245,"median":-22.645883,"eighty":-18.070517,"marketCap":1999521939},{"date":"2024-04-05","current":-20.434088,"twenty":-29.301795,"median":-22.601624,"eighty":-18.089549,"marketCap":1831303011},{"date":"2024-04-12","current":-20.928042,"twenty":-29.107626,"median":-22.568955,"eighty":-18.098906,"marketCap":1875571150},{"date":"2024-04-19","current":-18.81184,"twenty":-29.061939,"median":-22.455039,"eighty":-18.224405,"marketCap":1685917123},{"date":"2024-04-26","current":-20.267704,"twenty":-28.863962,"median":-22.311113,"eighty":-18.256547,"marketCap":1816391638},{"date":"2024-05-03","current":-20.281918,"twenty":-28.794162,"median":-22.289169,"eighty":-18.270537,"marketCap":1817665530},{"date":"2024-05-10","current":-20.105056,"twenty":-28.789086,"median":-22.270856,"eighty":-18.288305,"marketCap":1801815151},{"date":"2024-05-17","current":-17.123915,"twenty":-28.636796,"median":-22.232392,"eighty":-18.098906,"marketCap":1672681180},{"date":"2024-05-24","current":-18.288418,"twenty":-28.476893,"median":-22.116999,"eighty":-18.062811,"marketCap":1786430959},{"date":"2024-05-31","current":-16.11295,"twenty":-28.435013,"median":-22.068918,"eighty":-17.902107,"marketCap":1573929112},{"date":"2024-06-07","current":-26.55105,"twenty":-28.381712,"median":-22.102574,"eighty":-17.902107,"marketCap":2593533072},{"date":"2024-06-14","current":-24.646705,"twenty":-28.337752,"median":-22.198735,"eighty":-17.932407,"marketCap":2407514791},{"date":"2024-06-21","current":-22.312809,"twenty":-28.3175,"median":-22.24579,"eighty":-17.974375,"marketCap":2179537500},{"date":"2024-06-28","current":-18.680713,"twenty":-28.3175,"median":-22.24579,"eighty":-18.00318,"marketCap":1824750754},{"date":"2024-07-05","current":-17.874111,"twenty":-28.267548,"median":-22.198735,"eighty":-17.932407,"marketCap":1745961056},{"date":"2024-07-12","current":-20.408464,"twenty":-28.068249,"median":-22.08815,"eighty":-17.932407,"marketCap":1993519219},{"date":"2024-07-15","current":-20.943017,"twenty":-28.006064,"median":-22.078534,"eighty":-17.941595,"marketCap":2045734877},{"date":"2024-08-02","current":-17.387286,"twenty":-27.943879,"median":-22.068918,"eighty":-17.908069,"marketCap":1698407510},{"date":"2024-08-09","current":-16.461364,"twenty":-27.802578,"median":-21.942986,"eighty":-17.823234,"marketCap":1607962532},{"date":"2024-08-16","current":-20.792004,"twenty":-27.780694,"median":-21.876596,"eighty":-17.821691,"marketCap":2088244945},{"date":"2024-08-23","current":-22.295452,"twenty":-27.74971,"median":-21.929398,"eighty":-17.823234,"marketCap":2239243758},{"date":"2024-08-30","current":-21.822777,"twenty":-27.716713,"median":-21.953525,"eighty":-17.863936,"marketCap":2191770646},{"date":"2024-09-06","current":-21.851252,"twenty":-27.691332,"median":-21.926349,"eighty":-17.874111,"marketCap":2194630472},{"date":"2024-09-13","current":-22.944669,"twenty":-27.671026,"median":-21.901472,"eighty":-17.880178,"marketCap":2304447790},{"date":"2024-09-20","current":-22.067657,"twenty":-27.608415,"median":-21.926349,"eighty":-17.902107,"marketCap":2216365150},{"date":"2024-09-27","current":-23.650834,"twenty":-27.565171,"median":-22.001606,"eighty":-17.941595,"marketCap":2375371475},{"date":"2024-10-04","current":-24.083644,"twenty":-27.536769,"median":-22.068918,"eighty":-18.000093,"marketCap":2418840830},{"date":"2024-10-11","current":-22.130301,"twenty":-27.481934,"median":-22.12365,"eighty":-18.029927,"marketCap":2222656767},{"date":"2024-10-18","current":-22.563112,"twenty":-27.163394,"median":-22.116999,"eighty":-18.055104,"marketCap":2266126122},{"date":"2024-10-25","current":-21.333018,"twenty":-26.967956,"median":-22.11226,"eighty":-18.070517,"marketCap":2142581639},{"date":"2024-10-31","current":-21.560813,"twenty":-26.932422,"median":-22.097835,"eighty":-18.080033,"marketCap":2165460247},{"date":"2024-11-08","current":-21.839862,"twenty":-26.875803,"median":-22.107521,"eighty":-18.096607,"marketCap":2193486542},{"date":"2024-11-15","current":-19.500107,"twenty":-26.820843,"median":-22.068288,"eighty":-18.16223,"marketCap":2155736838},{"date":"2024-11-22","current":-15.573182,"twenty":-26.740791,"median":-22.039183,"eighty":-18.047398,"marketCap":1721615252},{"date":"2024-11-29","current":-17.170432,"twenty":-26.702879,"median":-21.932448,"eighty":-17.923218,"marketCap":1898191276},{"date":"2024-12-06","current":-16.181125,"twenty":-26.575564,"median":-21.883856,"eighty":-17.833409,"marketCap":1788823393},{"date":"2024-12-13","current":-16.424567,"twenty":-26.524021,"median":-21.851252,"eighty":-17.817061,"marketCap":1815735909},{"date":"2024-12-20","current":-15.523314,"twenty":-26.386717,"median":-21.835102,"eighty":-17.715324,"marketCap":1716102339},{"date":"2024-12-27","current":-15.30059,"twenty":-26.269962,"median":-21.822777,"eighty":-17.687076,"marketCap":1691480250},{"date":"2025-01-03","current":-14.601342,"twenty":-26.20397,"median":-21.78933,"eighty":-17.625803,"marketCap":1614178343},{"date":"2025-01-10","current":-14.005686,"twenty":-26.17605,"median":-21.782692,"eighty":-17.604018,"marketCap":1548328570},{"date":"2025-01-17","current":-13.974608,"twenty":-26.160821,"median":-21.780436,"eighty":-17.514986,"marketCap":1544892930},{"date":"2025-01-24","current":-14.482211,"twenty":-26.10752,"median":-21.737354,"eighty":-17.469621,"marketCap":1601008389},{"date":"2025-01-31","current":-15.7046,"twenty":-26.035182,"median":-21.700984,"eighty":-17.381485,"marketCap":1736143575},{"date":"2025-02-07","current":-15.549212,"twenty":-26.032644,"median":-21.680405,"eighty":-17.295679,"marketCap":1718965373},{"date":"2025-02-14","current":-12.622728,"twenty":-25.9819,"median":-21.605123,"eighty":-17.234446,"marketCap":1395442576},{"date":"2025-02-21","current":-12.115125,"twenty":-25.903236,"median":-21.581883,"eighty":-17.21037,"marketCap":1339327118},{"date":"2025-02-28","current":-11.819887,"twenty":-25.84482,"median":-21.567582,"eighty":-17.171628,"marketCap":1306688535},{"date":"2025-03-07","current":-11.01217,"twenty":-25.735679,"median":-21.559435,"eighty":-17.124089,"marketCap":1349277189},{"date":"2025-03-14","current":-9.547313,"twenty":-25.689992,"median":-21.491953,"eighty":-17.045645,"marketCap":1169794078},{"date":"2025-03-21","current":-10.235281,"twenty":-25.609403,"median":-21.417887,"eighty":-16.960589,"marketCap":1254088063},{"date":"2025-03-28","current":-9.33203,"twenty":-25.527539,"median":-21.321628,"eighty":-16.93886,"marketCap":1143416369},{"date":"2025-04-04","current":-7.64253,"twenty":-25.480594,"median":-21.202701,"eighty":-16.831205,"marketCap":936408691},{"date":"2025-04-11","current":-7.043483,"twenty":-25.340669,"median":-21.061141,"eighty":-16.666093,"marketCap":863009847},{"date":"2025-04-17","current":-8.672143,"twenty":-25.329214,"median":-21.042579,"eighty":-16.563339,"marketCap":1062562954},{"date":"2025-04-25","current":-11.068331,"twenty":-25.25285,"median":-20.951128,"eighty":-16.426861,"marketCap":1356158331},{"date":"2025-05-02","current":-12.790591,"twenty":-25.171712,"median":-20.933479,"eighty":-16.305436,"marketCap":1567180008},{"date":"2025-05-09","current":-12.551909,"twenty":-25.070517,"median":-20.891345,"eighty":-16.181125,"marketCap":1537935156},{"date":"2025-05-16","current":-9.774326,"twenty":-25.068859,"median":-20.829252,"eighty":-16.056814,"marketCap":1400885752},{"date":"2025-05-23","current":-9.895696,"twenty":-25.0453,"median":-20.693431,"eighty":-15.839386,"marketCap":1418280862},{"date":"2025-05-30","current":-9.000467,"twenty":-25.01052,"median":-20.672234,"eighty":-15.745511,"marketCap":1289973912},{"date":"2025-06-06","current":-8.619091,"twenty":-25.001825,"median":-20.550917,"eighty":-15.544032,"marketCap":1235314001},{"date":"2025-06-13","current":-8.920177,"twenty":-24.996225,"median":-20.487391,"eighty":-15.387426,"marketCap":1278466562},{"date":"2025-06-20","current":-8.679308,"twenty":-24.952868,"median":-20.449033,"eighty":-14.973238,"marketCap":1243944513},{"date":"2025-06-27","current":-8.462526,"twenty":-24.918331,"median":-20.434088,"eighty":-14.66039,"marketCap":1212874668},{"date":"2025-07-03","current":-8.175491,"twenty":-24.875783,"median":-20.408464,"eighty":-14.607558,"marketCap":1171735893},{"date":"2025-07-11","current":-7.587369,"twenty":-24.818526,"median":-20.385744,"eighty":-14.451133,"marketCap":1087444556},{"date":"2025-07-18","current":-7.840282,"twenty":-24.807686,"median":-20.281918,"eighty":-14.123781,"marketCap":1123692707},{"date":"2025-07-25","current":-7.334457,"twenty":-24.781668,"median":-20.180483,"eighty":-13.987039,"marketCap":1051196404},{"date":"2025-08-01","current":-7.145777,"twenty":-24.722332,"median":-20.085721,"eighty":-13.108576,"marketCap":1024154132},{"date":"2025-08-08","current":-5.211405,"twenty":-24.651853,"median":-19.971704,"eighty":-12.812535,"marketCap":932580977},{"date":"2025-08-15","current":-5.964179,"twenty":-24.61951,"median":-19.937893,"eighty":-12.626872,"marketCap":1067289809},{"date":"2025-08-22","current":-6.234546,"twenty":-24.540145,"median":-19.829477,"eighty":-12.490132,"marketCap":1115672078},{"date":"2025-08-29","current":-6.160517,"twenty":-24.4698,"median":-19.66456,"eighty":-12.119485,"marketCap":1102424552},{"date":"2025-09-05","current":-6.360074,"twenty":-24.389808,"median":-19.576169,"eighty":-11.77845,"marketCap":1138135274},{"date":"2025-09-12","current":-6.720564,"twenty":-24.139365,"median":-19.456275,"eighty":-11.057099,"marketCap":1202644966},{"date":"2025-09-19","current":-7.47695,"twenty":-24.11098,"median":-19.134734,"eighty":-10.896967,"marketCap":1338000122},{"date":"2025-09-26","current":-8.043434,"twenty":-24.072254,"median":-19.014985,"eighty":-10.567565,"marketCap":1439372495},{"date":"2025-10-03","current":-8.568076,"twenty":-24.020356,"median":-18.941828,"eighty":-10.325716,"marketCap":1533257136},{"date":"2025-10-10","current":-9.833009,"twenty":-23.986828,"median":-18.81071,"eighty":-10.186609,"marketCap":1759617036},{"date":"2025-10-17","current":-8.87063,"twenty":-23.947347,"median":-18.74276,"eighty":-9.917033,"marketCap":1587399198},{"date":"2025-10-24","current":-8.548764,"twenty":-23.914099,"median":-18.661907,"eighty":-9.852324,"marketCap":1529801259},{"date":"2025-10-31","current":-10.370526,"twenty":-23.886602,"median":-18.351918,"eighty":-9.836476,"marketCap":1855805594},{"date":"2025-11-07","current":-10.772858,"twenty":-23.868757,"median":-18.327399,"eighty":-9.850579,"marketCap":1927803018},{"date":"2025-11-14","current":-10.08006,"twenty":-23.852048,"median":-18.288418,"eighty":-9.817863,"marketCap":2123717400},{"date":"2025-11-21","current":-9.889979,"twenty":-23.841601,"median":-18.256152,"eighty":-9.836476,"marketCap":2083670157},{"date":"2025-11-28","current":-10.313341,"twenty":-23.799814,"median":-18.097181,"eighty":-9.841018,"marketCap":2172866288},{"date":"2025-12-05","current":-9.460856,"twenty":-23.776121,"median":-18.070517,"eighty":-9.814076,"marketCap":1993260474},{"date":"2025-12-12","current":-19.422835,"twenty":-23.650834,"median":-18.082412,"eighty":-9.833009,"marketCap":4092100041},{"date":"2025-12-19","current":-17.985707,"twenty":-23.62393,"median":-18.070517,"eighty":-9.841018,"marketCap":3789318618},{"date":"2025-12-26","current":-22.869735,"twenty":-23.621272,"median":-18.100056,"eighty":-9.848479,"marketCap":4818310220},{"date":"2026-01-02","current":-22.823793,"twenty":-23.615623,"median":-18.255492,"eighty":-9.851048,"marketCap":4808630734},{"date":"2026-01-09","current":-21.980412,"twenty":-23.576442,"median":-18.281194,"eighty":-9.851517,"marketCap":4630943013},{"date":"2026-01-16","current":-27.900487,"twenty":-23.621936,"median":-18.326514,"eighty":-9.853937,"marketCap":5878214018},{"date":"2026-01-23","current":-30.148409,"twenty":-23.790337,"median":-18.349084,"eighty":-9.86147,"marketCap":6351817477},{"date":"2026-01-30","current":-28.599475,"twenty":-23.883185,"median":-18.63625,"eighty":-9.874048,"marketCap":6025480495},{"date":"2026-02-06","current":-24.024872,"twenty":-24.012922,"median":-18.680713,"eighty":-9.881446,"marketCap":5061680173},{"date":"2026-02-13","current":-23.64092,"twenty":-24.104146,"median":-18.735704,"eighty":-9.886523,"marketCap":4980787319},{"date":"2026-02-20","current":-22.141212,"twenty":-24.072254,"median":-18.787312,"eighty":-9.891122,"marketCap":4664821216},{"date":"2026-02-27","current":-21.248606,"twenty":-24.026331,"median":-18.905431,"eighty":-9.903769,"marketCap":4476762617},{"date":"2026-03-06","current":-29.951815,"twenty":-24.389808,"median":-18.958825,"eighty":-9.939515,"marketCap":4229256176},{"date":"2026-03-13","current":-27.383083,"twenty":-24.63457,"median":-19.091174,"eighty":-9.953915,"marketCap":3866546098},{"date":"2026-03-20","current":-25.316057,"twenty":-24.813106,"median":-19.247915,"eighty":-9.965451,"marketCap":3574677833},{"date":"2026-03-27","current":-23.178791,"twenty":-24.786548,"median":-19.412443,"eighty":-10.00684,"marketCap":3272891714},{"date":"2026-04-02","current":-25.170562,"twenty":-24.791427,"median":-19.500107,"eighty":-10.024679,"marketCap":3554133708},{"date":"2026-04-10","current":-27.664038,"twenty":-24.924896,"median":-19.588971,"eighty":-10.070397,"marketCap":3906217513},{"date":"2026-04-17","current":-26.841241,"twenty":-25.001825,"median":-19.762743,"eighty":-10.08006,"marketCap":3790036942},{"date":"2026-04-24","current":-23.59019,"twenty":-25.001825,"median":-19.852578,"eighty":-10.16646,"marketCap":3330982000},{"date":"2026-05-01","current":-20.863024,"twenty":-25.001825,"median":-19.937893,"eighty":-10.183801,"marketCap":2945900742},{"date":"2026-05-08","current":-19.705365,"twenty":-24.994825,"median":-19.961493,"eighty":-10.197841,"marketCap":2782437010},{"date":"2026-05-15","current":-16.62279,"twenty":-24.933886,"median":-19.910742,"eighty":-10.230435,"marketCap":2831476129},{"date":"2026-05-22","current":-16.184689,"twenty":-24.924896,"median":-19.829477,"eighty":-10.235281,"marketCap":2756851382}],"updateTime":1779814850387},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GPCR\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603100641","title":"Structure Therapeutics CEO Says Strategic Partner for Commercialization of Its Medicine Needs to Have Strong Relationships With Primary Care Doctors","url":"https://stock-news.laohu8.com/highlight/detail?id=2603100641","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603100641?lang=en_us&edition=fundamental","pubTime":"2026-01-15 03:37","pubTimestamp":1768419455,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nFWN3YF1T4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4599","BK4007","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603896637","title":"What to Watch in the Day Ahead - Wednesday, January 14","url":"https://stock-news.laohu8.com/highlight/detail?id=2603896637","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603896637?lang=en_us&edition=fundamental","pubTime":"2026-01-14 03:31","pubTimestamp":1768332717,"startTime":"0","endTime":"0","summary":"What to Watch in the Day Ahead - Wednesday, January 14The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ah","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nL6N3YE19H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","LU2236285917.USD","LU1814569148.SGD","LU0130517989.USD","LU1720051108.HKD","LU0345770308.USD","IE00BSNM7G36.USD","IE0002141913.USD","LU0208291251.USD","LU0114720955.EUR","LU1670710661.SGD","LU0098860793.USD","LU1894683348.USD","GPCR","LU0237698245.USD","LU0820562030.AUD","LU0708994859.HKD","LU1267930227.SGD","LU2129689514.USD","BAC","LU1974910355.USD","LU2023250843.SGD","LU0345769631.USD","LU1244550577.SGD","IE00BYXW3230.USD","BK4559","LU1506573853.SGD","LU2237443895.HKD","LU2360032135.SGD","LU2361045086.USD","LU0868494708.USD","LU1720051017.SGD","LU0162691827.USD","LU0985481810.HKD","LU1868836591.USD","LU1868837136.USD","LU0306806265.USD","LU1551013425.SGD","BK4553","LU0320765489.SGD","LU2265009873.SGD","LU2237443978.SGD","LU0170899867.USD","BK4588","LU2461242641.AUD","LU2054465674.USD","BMY","LU0265550359.USD","LU0061475181.USD","LU2552382058.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603763977","title":"Structure Therapeutics rises 14.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603763977","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603763977?lang=en_us&edition=fundamental","pubTime":"2026-01-14 01:05","pubTimestamp":1768323946,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) is up 14.1%, or $9.79 to $79.15. Published first on TheFly – the ultimate source for real-time, market-moving breakin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-rises-14-1-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-rises-14-1-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4599","GPCR","BK4139","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603523949","title":"What to Watch in the Day Ahead - Tuesday, January 13","url":"https://stock-news.laohu8.com/highlight/detail?id=2603523949","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603523949?lang=en_us&edition=fundamental","pubTime":"2026-01-13 03:30","pubTimestamp":1768246210,"startTime":"0","endTime":"0","summary":"What to Watch in the Day Ahead - Tuesday, January 13The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nL6N3YD0VG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4500","LU0048584097.USD","LU1244550494.USD","BK4533","LU0203345920.USD","LU2213496289.HKD","LU2054465674.USD","LU0211328371.USD","IE00BDRTCR15.USD","LU1496350502.SGD","LU1720051108.HKD","LU1894683348.USD","LU0689472784.USD","LU2236285917.USD","LU1917777945.USD","GPCR","BK4008","LU0787776722.HKD","IE00BBT3K403.USD","LU2237443622.USD","LU2023250843.SGD","LU1894683264.USD","IE00BDCRKT87.USD","LU0683600562.USD","LU1064131342.USD","IE00BZ1G4Q59.USD","LU1280957306.USD","LU0251132253.USD","LU1145028129.USD","LU2237443978.SGD","LU0265550359.USD","LU0868494708.USD","LU1670627923.USD","BK4207","IE00BYXW3230.USD","LU0868494617.USD","LU1496350171.SGD","LU0234572021.USD","LU1914381329.SGD","BK4566","LU0256863811.USD","LU0211331839.USD","LU1084165304.USD","LU1116320901.HKD","IE00BJLML261.HKD","IE00B1XK9C88.USD","DAL","LU0345769631.USD","LU1244550221.USD","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603424785","title":"Funding for Risky Biotechs Is Returning -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2603424785","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603424785?lang=en_us&edition=fundamental","pubTime":"2026-01-13 01:00","pubTimestamp":1768237200,"startTime":"0","endTime":"0","summary":"Wall Street is opening its coffers again for risky drug developers.Many small biotechnology companies have struggled to raise money in recent years. Public markets were all but shut. Initial public offerings slowed to a trickle and follow-on share sales, used by already-public companies to raise more funding, were muted. Some biotechs shut down.Yet investors began writing more checks toward the end of last year, giving some firms much-needed funding to pay for their costly research.Drug developers and other life-sciences companies traded on U.S. exchanges raised more than $13 billion from issuing new stock in the fourth quarter, the most for any quarter since the second quarter of 2021, according to data from LSEG, a financial-data provider.Apogee Therapeutics, which is developing treatments for immune diseases, raised some $345 million from investors in October, more than its $300 million target.Funding is crucial for startups. They are often years away from producing any revenue from","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4599","BK4505","LU0053671581.USD","BK4007","BK4585","GPCR","BK4139","APGE","DYN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603928544","title":"Structure Therapeutics Inc. unveils oral obesity treatment pipeline in new corporate presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2603928544","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603928544?lang=en_us&edition=fundamental","pubTime":"2026-01-13 00:05","pubTimestamp":1768233951,"startTime":"0","endTime":"0","summary":"Structure Therapeutics Inc. released a corporate presentation detailing its current approach and pipeline in the development of oral small molecule treatments for obesity and related metabolic conditions. The company highlighted the significant unmet need for accessible obesity treatments worldwide, noting that current injectable GLP-1 therapies address less than 5% of the potential market in the United States. Structure Therapeutics is advancing several oral small molecule candidates, including the GLP-1 receptor agonist Aleniglipron, which is Phase 3 ready, and two amylin candidates  in early-stage clinical development. The presentation emphasized the pharmacologic and economic advantages of oral small molecules over oral peptides, including ease of administration, combination potential, scalability, and cost benefits. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. W","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL8pb19B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4599","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602130545","title":"Septerna to Present GPCR Pipeline Updates at JPM Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2602130545","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602130545?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:13","pubTimestamp":1768227190,"startTime":"0","endTime":"0","summary":"An update from Septerna, Inc. ( ($SEPN) ) is now available. Septerna announced that during the week of January 12, 2026 it will meet investors and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/septerna-to-present-gpcr-pipeline-updates-at-jpm-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/septerna-to-present-gpcr-pipeline-updates-at-jpm-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2381873111.SGD","IE00B3S45H60.SGD","IE00BLSP4452.SGD","LU0345769631.USD","LU1261432733.SGD","LU0170899867.USD","IE00BZ1G4Q59.USD","IE00BDCRKT87.USD","LU1988902786.USD","LU2211815571.USD","LU0345770308.USD","LU0820561818.USD","LU1032466523.USD","LU2462157665.USD","IE0034235188.USD","LU1670627923.USD","LU2237443895.HKD","IE00BWXC8680.SGD","LU2237443382.USD","IE000M9KFDE8.USD","LU0106831901.USD","LU2417539215.USD","IE00B1BXHZ80.USD","LU0265550359.USD","GPCR","LU2357305700.SGD","IE00BJTD4V19.USD","LU0211328371.USD","LU0345769128.USD","LU2264538146.SGD","IE00BYXW3230.USD","LU1162221912.USD","SEPN","LU0964807845.USD","LU1974910355.USD","LU0345770993.USD","IE00BJTD4N35.SGD","LU1917777945.USD","LU1244550221.USD","LU2213496289.HKD","SG9999002232.USD","LU0208291251.USD","LU0006306889.USD","LU2242649171.HKD","SG9999002224.SGD","LU1894683348.USD","LU2756315318.SGD","IE00B1XK9C88.USD","IE00B775SV38.USD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602318590","title":"Press Release: Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2602318590","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602318590?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:05","pubTimestamp":1767906300,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Jan. 08, 2026  -- Septerna, Inc. , a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor  drug discovery, today announced the appointment of Mark A. Wilson as Chief Legal Officer. Mr. Wilson is an accomplished pharmaceutical and biotech executive with more than 25 years of experience across intellectual property, corporate legal, strategic collaborations and corporate governance matters.\"We are thrilled to welcome Mark to the team,\" said Jeffrey Finer, M.D., Ph.D., Chief Executive Officer and Co-founder of Septerna. \"His deep expertise across intellectual property strategy and corporate legal matters will be instrumental as we continue to strengthen our governance framework and maximize the value of our portfolio and proprietary Native Complex Platform. Mark's leadership will be vital as we scale the capabilities needed to execute on our long-term strategy and deliver new medicines for patients.\". \"Septerna represents an ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","BK4585","BK4588","BK4099","SEPN","BK4007","BK4555","BK4599","03160","GPCR","BK4604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146401006","title":"Weight-Loss Drugmakers' Stocks Jump. Structure Therapeutics up 5%; Eli Lilly Rises 4% to Record High; Amgen up 3%; Roche, Novo up Around 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146401006","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146401006?lang=en_us&edition=fundamental","pubTime":"2026-01-07 23:15","pubTimestamp":1767798955,"startTime":"0","endTime":"0","summary":"Weight-loss drugmakers' stocks jumped on Wednesday. Structure Therapeutics up 5%; Eli Lilly rose 4% to record high; Amgen up 3%; Roche, Novo up around 2%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Weight-Loss Drugmakers' Stocks Jump. Eli Lilly Rises 4% to Record High","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","AMGN","PFE","NVO","LLY","RHHBY","VKTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123730705","title":"Weight-Loss Drugmakers' Stocks Jump. Arrowhead up over 17%; Structure Therapeutics up over 6%; Novo Nordisk up 5%; Viking, Pfizer, Eli Lilly up Around 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123730705","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123730705?lang=en_us&edition=fundamental","pubTime":"2026-01-06 23:05","pubTimestamp":1767711953,"startTime":"0","endTime":"0","summary":"Weight-loss drugmakers' stocks jumped. Arrowhead up over 17%; Structure Therapeutics up over 6%; Novo Nordisk up 5%; Viking, Pfizer, Eli Lilly up around 2%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"c7a5ad1f4c9cc897f075885965193731","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","VKTX","GPCR","NVO","AMGN","RHHBY","PFE"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2601814858","title":"BRIEF-Structure Therapeutics Inc - Gasherbrum Entered Agreement With Genentech And Roche - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2601814858","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601814858?lang=en_us&edition=fundamental","pubTime":"2026-01-06 06:15","pubTimestamp":1767651351,"startTime":"0","endTime":"0","summary":"BRIEF-Structure Therapeutics Inc - Gasherbrum Entered Agreement With Genentech And Roche - SEC FilingStructure Therapeutics Inc GPCR.O:STRUCTURE THERAPEUTICS INC - GASHERBRUM ENTERED AGREEMENT WITH GENENTECH AND ROCHE - SEC FILINGSTRUCTURE THERAPEUTICS INC - GENENTECH TO PAY GASHERBRUM $100 MILLION - SEC FILINGSource text: [ID:n0001104659-26-000620]Further company coverage: GPCR.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nFWN3Y60GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4007","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601837879","title":"Structure Therapeutics Inc - Genentech to Pay Gasherbrum $100 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2601837879","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601837879?lang=en_us&edition=fundamental","pubTime":"2026-01-06 05:09","pubTimestamp":1767647379,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nFWN3Y60GL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GPCR","BK4599","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601683787","title":"Structure Therapeutics Subsidiary Grants Genentech $100 Million License for GLP-1 Patents","url":"https://stock-news.laohu8.com/highlight/detail?id=2601683787","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601683787?lang=en_us&edition=fundamental","pubTime":"2026-01-06 05:08","pubTimestamp":1767647295,"startTime":"0","endTime":"0","summary":"Structure Therapeutics Inc. announced that its wholly-owned subsidiary, Gasherbrum Bio, Inc., has entered into a material agreement with Genentech, Inc. and F. Hoffmann-La Roche Ltd. Under the agreement, Gasherbrum has granted Genentech and Roche a non-exclusive, sublicensable, royalty-bearing license to certain patents covering a class of oral GLP-1 receptor agonists distinct from aleniglipron. Genentech will make a one-time, non-refundable payment of $100 million to Gasherbrum and will pay royalties at a low single digit rate on net sales of products containing CT-996, a proprietary compound owned by Genentech. The agreement does not affect Structure Therapeutics’ ongoing programs or grant Genentech any patent prosecution or enforcement rights.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDL4Rz0qt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GPCR","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600708537","title":"The Year-End 2025 Biotech Rally And What It Means For 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2600708537","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600708537?lang=en_us&edition=fundamental","pubTime":"2025-12-31 23:54","pubTimestamp":1767196440,"startTime":"0","endTime":"0","summary":"Biotechnology stocks are wrapping up 2025 on a high note, bouncing back from a rocky start to deliver some of the year’s most impressive gains. What began as a sector weighed down by tariff fears and political noise has transformed into one of the market’s standout performers, powered by deal making, drug approvals, and breakthrough clinical results. The big question heading into 2026 is simple: can this momentum last?The performance metrics speak volumes. The iShares Biotechnology ETF  has climbed 29.51% year to date through December 29, while the State Street SPDR S&P Biotech ETF  has done even better with gains around 35.84%. The Nasdaq Biotechnology Index sits at 5,766.59, marking a 34% jump for the year.Regulatory wins provided another boost. The FDA greenlit 44 new therapies in 2025, with 26 approvals coming in the second half alone. December saw notable wins including Cytokinetics Incorporated’s  Myqorzo for a heart condition, marking the company’s first approval after 27 years ","market":"sh","thumbnail":"/next-assets/images/benzinga-post-card-placeholder.svg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["/next-assets/images/benzinga-post-card-placeholder.svg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/25/12/49650052/the-year-end-2025-biotech-rally-and-what-it-means-for-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/25/12/49650052/the-year-end-2025-biotech-rally-and-what-it-means-for-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["IE0005OL40V9.USD","GPCR","CYTK","IE00BBT3K403.USD","JNJ","VRNA","QLD","IE00BVYPNW00.USD",".IXIC","USAW.SI","NQmain","TSYW.SI","OMER","SQQQ","LU2592432038.USD","LU1037948897.HKD","LU2089984988.USD","USJW.SI","TQQQ","MNQmain","ITCI","NVIW.SI","SG9999014906.USD","MRK","IBB","PSQ","QID","LU0306807586.USD","LU2063271972.USD","PFE","IE00B1BXHZ80.USD","BK4581","LU0471298694.HKD","LU2430703178.SGD","EYPT","IE00BJT1NW94.SGD","NVS","RNA","IONS","LU1116320737.USD","LU1935042991.SGD","BK4532","LU0256863811.USD","BK4505","MNPR","LU0823434740.USD","SG9999014880.SGD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2595777995","title":"BUZZ-Structure Therapeutics doubles while other obesity drug developers decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2595777995","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595777995?lang=en_us&edition=fundamental","pubTime":"2025-12-31 22:29","pubTimestamp":1767191374,"startTime":"0","endTime":"0","summary":"BUZZ-Structure Therapeutics doubles while other obesity drug developers decline ** Shares of Structure Therapeutics GPCR.O have more than doubled this year, after declining 33% in 2024 ** Structure earlier this month said its experimental oral obesity pill showed 11.3% reduction in weight at 120 mg dose at 36 weeks in mid-stage study** Shares of other obesity drug developers such as Viking Therapeutics VKTX.O and Altimmune ALT.O are set to end in red      ** Weight-loss drug market is surging, with biotech firms racing to win share in sector dominated by Novo Nordisk NOVOb.CO and Eli Lilly LLY.N** Analysts forecast the industry will generate about $150 billion in annual sales in the next decade** Shares of Viking are down 12.2% this year after more than doubling in 2024; company said its experimental weight-loss pill helped patients lose 12.2% of their body weight in mid-stage trial, missing Wall Street's top-end expectations of 15%** Shares of Altimmune have fallen 49.9% this year, se","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nL4N3Y10LP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2168563687.JPY","LU0198837287.USD","LU1868836914.USD","LU1988902786.USD","LU0466842654.USD","LU0006306889.USD","IE00B1XK9C88.USD","LU0079474960.USD","GB00BDT5M118.USD","LU2211815571.USD","LU2265009873.SGD","LU2237443549.SGD","IE0002141913.USD","BK4516","LU1868836591.USD","LU0820561818.USD","LU1093756168.USD","LU0417517546.SGD","LU1366192091.USD","LU1983299246.USD","IE00B4R5TH58.HKD","LU0320765059.SGD","LU0823434740.USD","IE0009355771.USD","LU0943347566.SGD","LU0683600562.USD","LU0353189680.USD","LU0820561909.HKD","LU0823416689.USD","LU0266013472.USD","LU0456855351.SGD","LU1551013342.USD","SG9999015952.SGD","LU2750360641.GBP","LU2063271972.USD","LU2087625088.SGD","IE00BKDWB100.SGD","LU0787776722.HKD","LU0889565916.HKD","LU2361044865.SGD","LU2746668974.SGD","LU1232071149.USD","LU2236285917.USD","LU2552382132.HKD","LU0106261372.USD","SG9999017495.SGD","SG9999018865.SGD","SG9999015945.SGD","LU2461242641.AUD","LU0109391861.USD","LU2237443382.USD","LU2237443465.HKD","LU0353189763.USD","SGXZ31699556.SGD","LU1064131342.USD","LU2552382058.USD","LU0203202063.USD","LU1720051108.HKD","LU0354030438.USD","LU1057294990.SGD","LU0354030511.USD","IE00B2B36J28.USD","LU0323591593.USD","LU0786609619.USD","LU2750360997.AUD","LU0689472784.USD","SGXZ81514606.USD","LU2491050154.USD","LU2471134952.CNY","IE0005OL40V9.USD","LU0256863811.USD","BK4534","LU0320765992.SGD","LU2106854487.HKD","LU2168564222.USD","LU2237443978.SGD","LU0823434583.USD","LU2746668461.USD","LU1917777945.USD","BK4139","LU1023059063.AUD","SG9999014880.SGD","LU1093756325.SGD","LU1267930730.SGD","LU2360106947.USD","LU1548497426.USD","LU2361044949.HKD","GPCR","IE00BFTCPJ56.SGD","LU0096364046.USD","SG9999001176.SGD","LU2023250504.SGD","IE00B775H168.HKD","LU0061475181.USD","IE00B4JS1V06.HKD","LU0708995401.HKD","SGXZ57979304.SGD","BK4533","LU0058720904.USD","SGXZ99366536.SGD","IE00BN29S564.USD","LU0672654240.SGD","LU0114720955.EUR","LU1868836757.USD","LU1280957306.USD","LU1323610961.USD","SG9999001176.USD","IE0004445015.USD","LU1868837300.USD","IE00BFSS7M15.SGD","LU2361045086.USD","SGXZ51526630.SGD","IE0004445239.USD","LU0471298777.SGD","IE00BKPKM429.USD","LU2112291526.USD","LU1878469433.USD","LU2471134796.USD","LU2491049909.HKD","LU0238689110.USD","LU1127390331.HKD","LU0234572021.USD","LU2168564065.EUR","LU2357305700.SGD","LU0640476718.USD","LU1035775433.USD","LU1712237335.SGD","LU2264538146.SGD","LU2237438978.USD","BK4588","LU1868837136.USD","LU2462157665.USD","IE00BWXC8680.SGD","LU2602419157.SGD","IE00BK4W5L77.USD","IE00B7KXQ091.USD","SG9999015978.USD","IE00BJJMRY28.SGD","IE00BJT1NW94.SGD","LU0094547139.USD","LU1551013425.SGD","SG9999018857.SGD","LU1814569148.SGD","LU2471134523.USD","LU0316494557.USD","IE00BJJMRX11.SGD","LU2237443895.HKD","LU0385154629.USD","IE00BFSS8Q28.SGD","LU2324357040.USD","BK4585","LU1989771016.USD","BK4599","LU1974910355.USD","IE00BJLML261.HKD","LU0432979614.USD","LU0289739699.SGD","BK4581","LU1623119135.USD","SG9999014914.USD","IE00BJJMRZ35.SGD","IE00BK4W5M84.HKD","LU2237443622.USD","LU2168564149.EUR","LU2552382215.SGD","LU0109394709.USD","LU2108987350.USD","LU1061106388.HKD","LU1069344957.HKD","LU0122379950.USD","SG9999014898.SGD","LU2168564495.EUR","SG9999014906.USD","LU2491050071.SGD","IE00B1BXHZ80.USD","LU0203201768.USD","SG9999013999.USD","LU0471298694.HKD","LU2089984988.USD","LU1291159041.SGD","LU0256863902.USD","LU1804176565.USD","LU2456880835.USD","LU0097036916.USD","LU2417539215.USD","LU0882574055.USD","SG9999015986.USD","LU0882574139.USD","LU2468319806.SGD","LU1720051017.SGD","BK4007","LU2471134879.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592674381","title":"Structure Therapeutics Inc. : H.c. Wainwright Raises Target Price to $90 From $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2592674381","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592674381?lang=en_us&edition=fundamental","pubTime":"2025-12-19 21:45","pubTimestamp":1766151909,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nAZN4RH4QD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","GPCR","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592190039","title":"BUZZ-Obesity pill maker Structure gains after Lilly's pill shows promising trial data","url":"https://stock-news.laohu8.com/highlight/detail?id=2592190039","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592190039?lang=en_us&edition=fundamental","pubTime":"2025-12-18 23:31","pubTimestamp":1766071885,"startTime":"0","endTime":"0","summary":"BUZZ-Obesity pill maker Structure gains after Lilly's pill shows promising trial data** Structure Therapeutics shares GPCR.O up about 3% at $61.80** Eli Lilly LLY.N trial data shows its oral pill, orforglipron, helped patients maintain weight loss after switching from injectable GLP-1 drugs** J.P. Morgan says Lilly's data \"is a good read-across\" for GPCR's oral pill, aleniglipron, whose trial data is due H2 2026** GPCR shares had doubled on Dec 8 after aleni trial data showed weight loss of up to 11.3% after 36 weeks of treatment** Stock now up about 126% YTD, after a 33.5% drop in 2024** JPM thinks both orfo and aleni could be effective options for patients who want to move away from injectables long term  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nL4N3XO17I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BWXC8680.SGD","LU1623119135.USD","LU1035775433.USD","LU2461242641.AUD","SGXZ57979304.SGD","BK4599","LU2471134796.USD","LU2491050071.SGD","LU0882574055.USD","IE00BJLML261.HKD","SG9999018857.SGD","LU0354030438.USD","LU0061475181.USD","LU0289739699.SGD","LU2168563687.JPY","LU0114720955.EUR","LU2023250504.SGD","LU1366192091.USD","LU2746668974.SGD","LU1280957306.USD","SG9999017495.SGD","LU1232071149.USD","IE0002141913.USD","LU2552382058.USD","LU0198837287.USD","LU1988902786.USD","LU0823416689.USD","LU0256863811.USD","LU0787776722.HKD","IE00B7KXQ091.USD","SGXZ51526630.SGD","LU0203201768.USD","LU2237443549.SGD","BK4533","LU1323610961.USD","SG9999014906.USD","IE0004445239.USD","IE0004445015.USD","LU0471298777.SGD","LU2265009873.SGD","LU2264538146.SGD","LU0320765059.SGD","LU2106854487.HKD","LU2417539215.USD","IE00B4R5TH58.HKD","LU0079474960.USD","LU1127390331.HKD","LU2361045086.USD","BK4534","BK4516","LU2211815571.USD","SG9999015945.SGD","LU2168564222.USD","LU1868836757.USD","LU0238689110.USD","LU1720051017.SGD","LU0094547139.USD","LU1551013342.USD","LU2112291526.USD","LU2237443622.USD","LU1548497426.USD","LU1551013425.SGD","LU2456880835.USD","LU0943347566.SGD","LU0456855351.SGD","IE00BN29S564.USD","IE0005OL40V9.USD","LU0889565916.HKD","LU0823434583.USD","LU2237443382.USD","IE00B1BXHZ80.USD","LU0256863902.USD","LU1983299246.USD","LU2462157665.USD","LU2491049909.HKD","GB00BDT5M118.USD","LU0471298694.HKD","LU0786609619.USD","LU0203202063.USD","LU0640476718.USD","LLY","LU0882574139.USD","LU0353189680.USD","LU0109394709.USD","LU0708995401.HKD","LU0820561818.USD","LU1064131342.USD","LU1974910355.USD","LU2087625088.SGD","LU2361044949.HKD","LU2750360997.AUD","IE00BK4W5M84.HKD","LU2108987350.USD","IE00B1XK9C88.USD","LU2552382132.HKD","GPCR","LU2746668461.USD","LU2237443895.HKD","SG9999014880.SGD","LU2552382215.SGD","LU1291159041.SGD","LU1814569148.SGD","BK4007","LU1069344957.HKD","LU2063271972.USD","LU1093756325.SGD","LU2089984988.USD","LU0823434740.USD","LU1267930730.SGD","IE00BFSS8Q28.SGD","LU2602419157.SGD","LU0354030511.USD","LU0122379950.USD","LU2357305700.SGD","LU2360106947.USD","LU0385154629.USD","LU2237443465.HKD","IE00BK4W5L77.USD","LU0096364046.USD","IE00B4JS1V06.HKD","SGXZ31699556.SGD","IE00BJJMRX11.SGD","LU0320765992.SGD","LU0417517546.SGD","SG9999001176.USD","LU0353189763.USD","LU1868836591.USD","LU1868837300.USD","LU0006306889.USD","LU2237438978.USD","BK4585","LU0689472784.USD","LU0323591593.USD","LU0432979614.USD","SG9999018865.SGD","LU2491050154.USD","LU0097036916.USD","LU1917777945.USD","LU1057294990.SGD","LU1061106388.HKD","SGXZ81514606.USD","SG9999014914.USD","IE00B2B36J28.USD","SG9999015986.USD","LU0466842654.USD","SGXZ99366536.SGD","IE00BFTCPJ56.SGD","LU0683600562.USD","IE00B775H168.HKD","LU2361044865.SGD","IE0009355771.USD","LU0820561909.HKD","IE00BKDWB100.SGD","LU2236285917.USD","LU2468319806.SGD","BK4588","SG9999013999.USD","LU1989771016.USD","SG9999014898.SGD","LU1720051108.HKD","LU1712237335.SGD","LU2237443978.SGD","LU0109391861.USD","LU2168564495.EUR","IE00BJT1NW94.SGD","LU1093756168.USD","LU2471134879.HKD","SG9999001176.SGD","LU2471134952.CNY","BK4581","LU0316494557.USD","IE00BJJMRY28.SGD","LU2324357040.USD","IE00BFSS7M15.SGD","IE00BKPKM429.USD","LU0266013472.USD","LU0234572021.USD","LU0672654240.SGD","SG9999015952.SGD","LU1804176565.USD","LU2750360641.GBP","LU1868836914.USD","LU1023059063.AUD","LU0106261372.USD","LU2168564065.EUR","LU2168564149.EUR","LU0058720904.USD","SG9999015978.USD","LU1868837136.USD","LU2471134523.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2592150739","title":"BRIEF-Structure Therapeutics Starts Phase 1 Study Of Oral Amylin Agonist ACCG‑2671","url":"https://stock-news.laohu8.com/highlight/detail?id=2592150739","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592150739?lang=en_us&edition=fundamental","pubTime":"2025-12-17 22:38","pubTimestamp":1765982287,"startTime":"0","endTime":"0","summary":"BRIEF-Structure Therapeutics Starts Phase 1 Study Of Oral Amylin Agonist ACCG2671Dec 17 (Reuters) - Structure Therapeutics Inc GPCR.O:STRUCTURE THERAPEUTICS ANNOUNCES INITIATION OF PHASE 1 CLINICAL ST","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUA5Z08HX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","BK4599","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592918919","title":"Structure Therapeutics Launches Phase 1 Trial of Oral Amylin Agonist ACCG-2671 for Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2592918919","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592918919?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:30","pubTimestamp":1765978232,"startTime":"0","endTime":"0","summary":"Structure Therapeutics Inc. has announced the initiation of a Phase 1 clinical study for ACCG-2671, its lead oral small molecule amylin receptor agonist developed for the treatment of obesity. ACCG-2671 was designed to leverage the metabolic benefits of amylin biology in an oral, once-daily small molecule format, with the goal of improving scalability, combinability, and patient access. The Phase 1 trial will assess the safety, tolerability, pharmacokinetics, and pharmacodynamic activity of ACCG-2671 in both healthy volunteers and individuals with obesity, utilizing single-ascending dose and multiple-ascending dose cohorts. Results from this study have not yet been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Structure The","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDLbvyFKk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BGHQF748.EUR","LU2210150020.SGD","SG9999014021.USD","SG9999014013.SGD","BK4007","BK4585","LU2210149790.SGD","GPCR","SG9999014039.USD","BK4588","IE00B64PRP62.GBP","SG9999014005.SGD","IE00BKPKM429.USD","BK4112","LU0314104364.USD","NDAQ","BK4599","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592918183","title":"Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist Accg-2671 for the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2592918183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592918183?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:30","pubTimestamp":1765978201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUA5Z08HX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GPCR","BK4599","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":5,"totalSize":130,"code":"91000000","status":"200"}]}}